Heehyoung Lee - 10 Oct 2023 Form 4 Insider Report for Calidi Biotherapeutics, Inc. (CLDI)

Role: Director, Former Director
Signature: /s/ Wendy Pizarro, Attorney-in-fact for Heehyoung Lee
Issuer symbol: CLDI
Transactions as of: 10 Oct 2023
Net transactions value: $0
Form type: 4
Filing time: 26 Oct 2023, 11:46:05 UTC
Previous filing: 25 Sep 2023
SEC: View on sec.gov

Heehyoung Lee is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

This "Exit" Form 4 is being voluntarily filed to report solely that the Reporting Person is no longer serving as the Company's director, effective as of October 10, 2023. Exhibit 24 - Power of Attorney (previously filed as Exhibit 24 to Form 3 dated September 25, 2023)